Press Resease

Cervical Cancer Diagnostics Market - Global Industry Analysis

Cervical Cancer Diagnostics Market - Global Industry Perspective, Comprehensive Analysis and Forecast 2020-2026

Published Date: 20-Aug-2020 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-84 Status : Published

Global demand for cervical cancer diagnostics market was valued at approximately USD 8,816.6 Million in 2019, and is expected to generate revenue of around USD 12,996.4 Million by end of 2026, growing at a CAGR of around 5.7% between 2020 and 2026

Description

According to the report, global demand for cervical cancer diagnostics market was valued at approximately USD 8,816.6 Million in 2019, and is expected to generate revenue of around USD 12,996.4 Million by end of 2026, growing at a CAGR of around 5.7% between 2020 and 2026.

Cancer is a group of diseases involving abnormal growth of cells with the potential to spread to other parts of the body. There are various types of cancers affecting different parts of body. Cancer which develops in cervix is called cervical cancer. Two major types of cervical cancers diagnosed in women include adenocarcinoma and squamous cell carcinoma. Almost all types of cervical cancer are caused by human papiloma virus (HPV). Cervical cancer is the third most common cancer among women and the second most frequent cause of cancer-related death, accounting for almost 3,00,000 deaths annually. Diagnosis of cervical cancer is done by Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC). Cervical cancer is a sexually transmitted disease that can be prevented by early detection and vaccination.

Cervical cancer diagnostics market is driven majorly by increasing percentage of HPV infected people across globe. HPV is an extremely common virus. According to the Centers for Disease Control and Prevention (CDC), six million people in the United States acquire HPV each year.  At least 20 million already have it, and more than half of all sexually-active adults are expected to be infected during their lifetime. Furthermore, rising awareness, literacy rate, government initiatives, government funding and various screening methods are expected to increase the growth of the market over the years. Moreover, many lifestyle-related factors, such as having multiple sex partners, smoking, obesity, unsafe sex and inherited HPV positive patients, are estimated to drive the cervical diagnostics market in the near future. However prevention of HPV by vaccination is major restraining factor in the growth of cervical cancer diagnostics market. In addition to this, the uncertain returning policy serves to be a major challenge impacting the growth of cervical cancer diagnostics market.

The report covers forecast and analysis of the cervical cancer diagnostics market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million).  To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the cervical cancer diagnostics market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate and general attractiveness.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

The report provides detailed segmentation of the cervical cancer diagnostics market based on application and region. The regional market segment held the largest market share in 2015.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global cervical cancer diagnostic market in 2015 on account of the rising incidence of HPV infection, rising number of women smokers, and growing aged population. North America was followed by Europe in 2015. The market is expected to witness the growth in the Asia-Pacific region in the coming years due to the rising HPV infection in population, government initiative and availability of advance health care infrastructure.

Some of the key players contributing to the cervical cancer diagnostics market are Abbott Laboratories, Qiagen N.V., Hologic Inc., Roche Diagnostics, Quest Diagnostics, Becton, Dickinson and Company

This report segments the cervical cancer diagnostics market are follows:-

Cervical Cancer Diagnostics Market: Application Analysis

  • Pap Smear Tests
  • Colposcopy
  • HPV Testing

Cervical Cancer Diagnostics Market: Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
    • 2.2. Cervical Cancer Diagnostics Market: Snapshot
  • Chapter 3. Cervical Cancer Diagnostics Market – Industry Analysis
    • 3.1. Cervical Cancer Diagnostics Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Growing incidence of cervical cancer in middle-aged women
      • 3.2.2. Increasing number of awareness programs for cervical cancer screening
    • 3.3. Restraints
      • 3.3.1. Changes in regulatory guidelines for cervical cancer screening
    • 3.4. Opportunities
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Test Type
      • 3.6.2. Market attractiveness analysis by Region
  • Chapter 4. Cervical Cancer Diagnostics Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Cervical Cancer Diagnostics Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Cervical Cancer Diagnostics Market – Test Type Analysis
    • 5.1. Global Cervical Cancer Diagnostics Market overview: by Test Type
      • 5.1.1. Global Cervical Cancer Diagnostics Market share, by Test Type, 2019 and 2026
    • 5.2. Pap Testing (Cytulogy Testing)
      • 5.2.1. Global Cervical Cancer Diagnostics Market by Pap Testing (Cytulogy Testing), 2016 – 2026 (USD Million)
    • 5.3. HPV Testing
      • 5.3.1. Global Cervical Cancer Diagnostics Market by HPV Testing, 2016 – 2026 (USD Million)
    • 5.4. Culposcopy
      • 5.4.1. Global Cervical Cancer Diagnostics Market by Culposcopy, 2016 – 2026 (USD Million)
    • 5.5. Cervical Biopsies
      • 5.5.1. Global Cervical Cancer Diagnostics Market by Cervical Biopsies, 2016 – 2026 (USD Million)
    • 5.6. Cystoscopy
      • 5.6.1. Global Cervical Cancer Diagnostics Market by Cystoscopy, 2016 – 2026 (USD Million)
  • Chapter 6. Global Cervical Cancer Diagnostics Market - Regional Analysis
    • 6.1. Global Cervical Cancer Diagnostics Market overview: by Region
      • 6.1.1. Global Cervical Cancer Diagnostics Market share, by Region, 2019 and 2026
    • 6.2. North America
      • 6.2.1. North America Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
      • 6.2.2. North America Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
      • 6.2.3. North America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
      • 6.2.4. U.S.
        • 6.2.4.1. U.S. Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
      • 6.2.5. Rest of North America
        • 6.2.5.1. Rest of North America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
      • 6.3.2. Europe Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
      • 6.3.3. Europe Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
      • 6.3.4. U.K.
        • 6.3.4.1. U.K. Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
      • 6.3.5. France
        • 6.3.5.1. France Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
      • 6.3.6. Germany
        • 6.3.6.1. Germany Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
      • 6.3.7. Rest of Europe
        • 6.3.7.1. Rest of Europe Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
      • 6.4.2. Asia Pacific Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
      • 6.4.3. Asia Pacific Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
      • 6.4.4. China
        • 6.4.4.1. China Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
      • 6.4.5. Japan
        • 6.4.5.1. Japan Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
      • 6.4.6. India
        • 6.4.6.1. India Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
      • 6.4.7. Rest of Asia Pacific
        • 6.4.7.1. Rest of Asia Pacific Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
      • 6.5.2. Latin America Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
      • 6.5.3. Latin America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
      • 6.5.4. Brazil
        • 6.5.4.1. Brazil Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
      • 6.5.5. Rest of Latin America
        • 6.5.5.1. Rest of Latin America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
    • 6.6. The Middle East and Africa
      • 6.6.1. The Middle East and Africa Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
      • 6.6.2. The Middle East and Africa Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
      • 6.6.3. The Middle East and Africa Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
      • 6.6.4. GCC Countries
        • 6.6.4.1. GCC Countries Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
      • 6.6.5. Rest of Middle East & Africa
        • 6.6.5.1. Rest of Middle East & Africa Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
  • Chapter 7. Company Profiles
    • 7.1. Abbott Laboratories
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Qiagen N.V.
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Hulogic Inc.
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. Roche Diagnostics
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Quest Diagnostics
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Becton, Dickinson and Company
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development

List of Figures

1. Market research process
2. Market research methodology
3. Global Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Cervical Cancer Diagnostics Market attractiveness, by Test Type
6. Global Cervical Cancer Diagnostics Market attractiveness, by Region
7. Global Cervical Cancer Diagnostics Market share, by Test Type, 2019 and 2026
8. Global Cervical Cancer Diagnostics Market by Pap Testing (Cytology Testing), 2016 – 2026 (USD Million)
9. Global Cervical Cancer Diagnostics Market by HPV Testing, 2016 – 2026 (USD Million)
10. Global Cervical Cancer Diagnostics Market by Colposcopy, 2016 – 2026 (USD Million)
11. Global Cervical Cancer Diagnostics Market by Cervical Biopsies, 2016 – 2026 (USD Million)
12. Global Cervical Cancer Diagnostics Market by Cystoscopy, 2016 – 2026 (USD Million)
13. Global Cervical Cancer Diagnostics Market share, by Region, 2019 and 2026
14. North America Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
15. Europe Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
16. Asia Pacific Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
17. Latin America Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)
18. The Middle East and Africa Cervical Cancer Diagnostics Market, 2016 – 2026 (USD Million)


List of Tables

1. Global Cervical Cancer Diagnostics Market: snapshot
2. Drivers of the Cervical Cancer Diagnostics Market: impact analysis
3. Restraints of the Cervical Cancer Diagnostics Market: impact analysis
4. North America Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
5. North America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
6. U.S. Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
7. Rest of North America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
8. Europe Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
9. Europe Cervical Cancer Diagnostics Market revenue, by End User, 2016 – 2026 (USD Million)
10. U.K. Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
11. France Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
12. Germany Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
13. Rest of Europe Cervical Cancer Diagnostics revenue, by Test Type, 2016 – 2026 (USD Million)
14. Asia Pacific Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
15. Asia Pacific Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
16. China Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
17. Japan Cervical Cancer Diagnostics revenue, by Test Type, 2016 – 2026 (USD Million)
18. India Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
19. Rest of Asia Pacific Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
20. Latin America Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
21. Latin America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
22. Brazil Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
23. Rest of Latin America Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
24. The Middle East and Africa Cervical Cancer Diagnostics Market revenue, by Country, 2016 – 2026 (USD Million)
25. The Middle East and Africa Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
26. GCC Countries Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
27. Rest of Middle East and Africa Cervical Cancer Diagnostics Market revenue, by Test Type, 2016 – 2026 (USD Million)
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed